$16.3B in revenue during H1 2026, up 14x year over year.

$693M operating loss, down from $2.1B a year earlier.

~$9B in compute and infrastructure spending over six months.

11,900+ customers spending at least $100K annually, including 1,900+ spending over $1M and roughly 250 spending over $10M.

~900% net revenue retention, highlighting how quickly existing customers are expanding their usage.

Clinical trials: Reducing the time required to produce clinical trial reports from months to minutes.

Drug discovery: Working with pharmaceutical companies to accelerate basic research and clinical development.

Biotechnology: Exploring AI-assisted molecular machine discovery, with potential applications in developing new biological tools.

Global health: Using AI for malaria modeling and other public health initiatives in collaboration with the WHO.

Radical Numerics: Omnii-1 designed phages that were administered to a patient with an antibiotic-resistant infection under compassionate use. (link)

Anthropic: Claude generated 318K+ protein designs targeting scorpion toxins. 211 were tested in the lab and 17 met Anthropic’s criteria for a binder. (link)

OpenAI: acquired Orchestra Bio and is bringing its drug-development agents into Rosalind. (link)

OpenAI + PerturbAI + Scripps: thousands of agents analyzed data from millions of brain cells in 32 minutes and surfaced new leads around Alzheimer’s and Parkinson’s. (link)

NVIDIA + UW Institute for Protein Design: released RFD4-Proteina, an open model that jointly designs protein sequences and all-atom structures. (link)

Microsoft: released BioEmu-2, a 500M-parameter model that generates ensembles of 3D biomolecular structures to study how molecules move and interact. (link)

Rosetta Commons: launched Chaperone, a framework for connecting tools like RFdiffusion3, AlphaFold3, ProteinMPNN, and Boltz into protein-design workflows. (link)

Ligo Biosciences: launched Artios, an open enzyme-design system that posted state-of-the-art results on its reported benchmarks. (link)

Xaira: launched X-Scientist for agentic drug discovery, then X-Automate to connect its AI agents with robotic lab equipment. (link)

Sophont: launched Holon-S1, which predicts spatial gene and pathway activity directly from routine pathology slides. (link)

Boltz + Bristol Myers Squibb: bringing Boltz’s biomolecular models into BMS drug-discovery workflows and working together on custom models using BMS scientific data. (link)

Phylo + Bayer: deploying Biomni Lab across Bayer research teams for literature, omics, and drug-discovery workflows. (link)

Warp Sciences: former OpenAI science lead Kevin Weil launched the company with a $215M Series A to combine AI, robotics, and automated labs for drug discovery. (link)

Hugging Face: released Carbon-X, an open 14.8B DNA model that reads raw DNA alongside natural language. Its team reports an average score of 66.7% across five DNA benchmarks versus 67.5% for GPT-6.1 Sol, at roughly 1/1,800 of the inference cost per problem. (link)

Microsoft’s diagnostic AI scores 83% on complex medical cases: MAI-DxO beat physicians using references, who scored 36%, across 304 simulated NEJM cases; prospective testing is planned at Beth Israel Deaconess. (link)

Speechmatics launches a multilingual medical speech model: Oak transcribes 55+ languages through one API and can follow clinicians and patients as they switch languages within the same conversation. (link)

Epic launches Connectors to link its AI agents with third-party apps: Built on MCP, Connectors let Epic’s Emmie, Art and Penny assistants access information and perform tasks across external applications. Developer-built Connectors will be available through Epic Showroom starting March 2027. (link)

careCycle launches a free Medicare plan comparison tool: Match Your Medicare compares up to 3 plans side by side, including estimated costs and in-network doctors. (link)

Inovia Bio launches AI workflows for drug development: Falcon drafts study protocols, clinical reports and forecasts in hours, the company says, with human review and sign-off. (link)

Talkiatry takes virtual therapy nationwide: The expansion broadens its behavioral health platform, supporting patients with needs ranging from routine therapy to more intensive care. (link)

Protege launches independent evaluations for healthcare AI: The program uses double-blind testing on real-world patient data, starting with a small cohort of AI developers. (link)

micro1 launches a Medical Index for AI models: The live leaderboard combines 3 expert-built evaluations covering pathology, FDA drug documentation and adolescent health safety. (link)

Eko launches FDA-cleared stethoscope with analog and digital listening: CORE 300 combines traditional listening with digital amplification and supports AI-assisted structural murmur detection through the Eko app. (link)

athenahealth connects clinics and surgery centers in athenaOne: The new ambulatory surgery center offering unifies patient records, scheduling, documentation and billing across clinic and surgical workflows. (link)

Vene launches an AI advocate for navigating healthcare: The company says 5,000+ families use its care coordination service, with rollout planned for 50,000 additional patients across provider networks. (link)

Concurrence launches Superintelligent Care research program: The initiative aims to combine fragmented patient records into models that forecast individual health and transfer insights across patients. (link)

Notable gives operators more control over their AI workforce: Flow Compass lets teams query automation performance, generate test cases, trace failures and track ROI through plain-language requests. (link)

Memorial Sloan Kettering + OpenEvidence: OncoKB brings MSK’s expert interpretation of tumor genetics into OpenEvidence for clinicians nationwide; over 85% of MSK oncologists already use the platform. (link)

UCSF + Conceivable Life Sciences: The planned UCSF Fertility Excellence Center will study AI-assisted IVF laboratory automation using Conceivable’s AURA platform, with embryologists supervising the technology. (link)

Sentara Health + Regard: The health system deployed a co-developed AI case management tool that lets case managers query patient charts in plain language to support care transitions. (link)

Microsoft + Opella: The partners are building Lumen, a platform with 14 AI agents that check health content claims, sources and compliance, with human experts retaining final approval. (link)

K Health + Wix: The partners will integrate PatientGPT’s record-grounded clinical AI into adaptive websites that personalize health system navigation around each patient’s history and needs. (link)

Doximity + Wolters Kluwer: The partnership will bring content from UpToDate’s 13,000 topics into Doximity Ask alongside AI-generated answers, with rollout expected in the coming weeks. (link)

Epic + Amazon Pharmacy + Cost Plus Drugs + Costco + LillyDirect: A planned prescription marketplace will let clinicians and patients compare insurance and cash drug prices before prescribing. (link)

Oracle Health + U.S. Department of Veterans Affairs: The VA’s EHR pharmacy module now supports AI-drafted pharmacist notes, with a Pharmacy Forward upgrade planned for 2027. (link)

Fortuna + R1 RCM: Fortuna will bring digital Medicaid enrollment into R1’s financial clearance workflows, connecting coverage enrollment with providers’ existing revenue cycle processes. (link)

Oura + Counsel Health: Eligible members can access medical AI and board-certified doctors inside the Oura app, with consent-based sharing of biometric data to inform their care. (link)

St. Luke’s Health System + hellocare.ai: The Idaho health system is deploying AI-assisted virtual nursing, telehealth and virtual patient observation across inpatient settings in Southern Idaho. (link)

Google Health + Flo Health: Consent-based app syncing will connect Flo’s cycle insights with wearable signals and Google Health Coach, with rollout beginning in early 2027. (link)

NVIDIA + Siemens Healthineers: The partners are exploring AI-assisted radiotherapy planning, patient-specific simulations and real-time computing to help clinicians adapt cancer treatment to individual patients. (link)

NVIDIA + Danaher + Benchling + Automata: Scientific agents will connect protein design with laboratory workflows, including Genedata’s planned use of RFD4-Proteina in Danaher’s autonomous lab. (link)

AI recommends care costing 3.2x as much as physicians: Across 200 cases, 20 general-purpose models recommended care averaging $314 per visit versus $97, using 2026 Medicare rates. (link)

Mass General Brigham AI estimates cancer survival from face photos: Researchers used FAHR-Face, trained on 40M+ images, to develop tools estimating biological age and survival risk. (link)

Mass General Brigham’s smaller AI beats larger clinical models: Trained on records from 3.6M patients, Clinical System One outperformed open models up to 27B parameters on 13 of 14 tasks in a preprint. (link)

Lirio reports 20%+ increase in vaccine uptake with AI outreach: The program reached millions of patients, with 40% of message recipients getting vaccinated, according to the company. (link)

63% would wait for human review of AI medical messages: In a 2024 survey of 1,185 adults, most preferred a 48-hour wait for clinician-reviewed medical replies over instant AI answers. (link)

Singapore researchers use casual speech to flag psychosis risk: NTU and IMH’s AI framework identified up to 93% of at-risk youths by analyzing emotional patterns in short speech samples. (link)

FDA expects draft generative AI device guidance within months: Its digital health director outlined the timeline after the agency received 300+ comments on its regulatory discussion paper. (link)

OpenAI discloses model bypassing security to retrieve hospital statistics: During internal training, the model retrieved server secrets and bypassed a government website’s authorization checks while researching hospital-bed counts. (link)

Iowa sues OpenAI over ChatGPT’s medical advice and safety: The attorney general alleges misleading safety claims and risks to vulnerable users, including dangerous medical advice; OpenAI disputes the allegations. (link)

Bob Wachter argues healthcare must deliberately encode AI’s values: The UCSF medicine chair says systems should make treatment tradeoffs visible and balance patient safety with appropriate testing and spending. (link)

OpenAI, is nearing a funding round of up to $30B at a $1.25T valuation, led by UAE investors. (link)

Warp Sciences, an AI drug discovery startup led by ex-OpenAI science head Kevin Weil, raised $215M in early-stage funding. Lightspeed Venture Partners led, joined by IVP, Lux Capital, and Premji Invest. (link)

Baba, an AI-powered patient advocacy startup for Medicare and Medicare Advantage, raised $40M in Series A funding led by FirstMark Capital, with CVS Health Ventures and Valtruis joining. The total funding is now $47M. (link)

Sunlight AI, a New York-based AI company that runs the business side of independent medical practices, launched with $17.4M in seed funding. Lan Xuexhao led, joined by Social Leverage and others. (link)

Kivo Health, a San Francisco-based telehealth provider for lung disease, raised $10M in Series A funding. Allumia Ventures led. (link)

BioStack, a San Francisco-based healthcare data network for training medical AI, raised $9.5M in seed funding. Peak XV Partners, Afore Capital, DCVC, Emerson Collective, and SV Angel participated. (link)

XRlabs, a London and Palo Alto-based surgical intelligence company, raised $8.4M in seed funding. Playground Global led, joined by Eka Ventures. (link)

Moodr Health, a West Virginia-based patient engagement platform for health plans and health systems, raised $3M in seed funding. (link)

Dr. Wachter on healthcare's alignment problem in the AI era (link)

Only 35% of healthcare AI pilots reach full production (link)

5 big healthcare predictions for 2027: Forrester (link)

Staff Growth Marketer at Abridge, an AI clinical documentation platform

$200K - $250K | San Francisco, New York City (link)

Technical Product Manager, EHR at Nabla, an ambient clinical AI platform

$140K - $180K | New York City (link)

Lead Product Data Analyst at Hippocratic AI, AI clinical agents for healthcare

N/A | Menlo Park, CA (link)